Despite numerous studies conducted over the past decade, the exact role of the
cannabinoid system in cancer development remains unclear. Though research has focused …

Multiple myeloma (MM) is characterized by aberrant bone marrow plasma cell (PC)
proliferation and is one of the most common hematological malignancies. The potential …

The anti-cancer effects of cannabinoids including CBD (Cannabidiol) and THC ((−)-trans-∆ 9-
tetrahydrocannabinol) have been reported in the case of pancreatic cancer (PC). The …

Background: We previously reported that cannabidiol (CBD), a cannabinoid with a low
toxicity profile, downregulated the expression of the prometastatic gene inhibitor of DNA …

Colorectal cancer is the third leading cause of cancer incidence and mortality in the United
States. Cannabidiol (CBD), the second most abundant phytocannabinoid in Cannabis …

Cannabinoids (CBs) are implicated in the control of cell survival in different types of tumors,
but little is known about the role of CB system in pancreatic cancer. Herein, we investigated …

Abstract Aim Cannabinoids (CB) like∆ 9-tetrahydrocannabinol (THC) can induce cancer cell
apoptosis and inhibit angiogenesis. However, the use of cannabinoids for the treatment of …

Cannabinoids have been utilized for recreational and therapeutic purposes for over 4,000
years. As the primary ingredient in exogenous cannabinoids, Cannabidiol (CBD) has drawn …

We report here that synthetic cannabinoid WIN 55,212–2 inhibits tumor cell proliferation and
induces cell death of oral and pancreatic tumor cells, and the effect is much more …

Objective Cannabinoids are able to reduce tumor growth in xenograft models, but their
therapeutic potential as anti-cancer drugs in humans is unclear yet. In vitro studies of the …